| 靶点: |
IC50: 30 nM (Factor D);Kd: 6 nM (Factor D) |
| 体内研究: |
Factor D inhibitor 6 (Compound 6; 1-10 mg/kg; Oral gavage; once; C57Bl/6 mice) treatment dosed-ependently inhibits complement activation, with full inhibition at 10 mg/kg. Factor D inhibitor 6 shows sustained inhibition of LPS-induced AP activation for at least 8 h post-dose with an EC50 of 0.034 μM. |
| 参考文献: |
1. Jürgen Maibaum, et al. Small-molecule Factor D Inhibitors Targeting the Alternative Complement Pathway. Nat Chem Biol. 2016 Dec;12(12):1105-1110. |
| 保存条件: |
-80℃(运输条件:冰袋低温运输) |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
2.062 ml |
10.311 ml |
20.622 ml |
| 5 mM |
0.412 ml |
2.062 ml |
4.124 ml |
| 10 mM |
0.206 ml |
1.031 ml |
2.062 ml |
| 50 mM |
0.041 ml |
0.206 ml |
0.412 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |